Non-Invasive Cardiac Output Monitoring Device Market is expected to reach US$ 3,30,902.81 thousand by 2027

Heart Failure Segment to Witness Rapid Growth During Forecast Period

According to our new research study on “Non-Invasive Cardiac Output Monitoring Device Market Forecast to 2027 – COVID-19 Impact and Analysis – by Device, Indication, and End User,” the market is expected to reach US$ 3,30,902.81 thousand by 2027 from US$ 2,26,049.76 thousand in 2019; it is estimated to grow at a CAGR of 5.0% from 2020 to 2027. The report highlights trends prevailing in the global non-invasive cardiac output monitoring device market and factors governing the market growth.

Based on indication, the non-invasive cardiac output monitoring device market is segmented into hypertension, coronary diseases, congenital problems, myocardial ischemia and infarction, heart failure, arrhythmias, and others. The hypertension segment held the largest share of the market in 2019; however, it is anticipated to register the highest CAGR during the forecast period. The rising prevalence of cardiovascular diseases is the prime factor contributing to the growth of the heart failure segment. Sedentary lifestyles, unhealthy diet, and mental stress are the main factors associated with the development of CVDs. As per the Centers for Disease Control and Prevention, heart failure was the cause of death recorded on 379,800 death certificates in the US in 2018.

The non-invasive cardiac output monitoring device market growth is mainly attributed to increase in prevalence of cardiovascular diseases and rise in geriatric population. However, the high cost of products and procedures is hindering the market growth.

Baxter, Bio-Beat, General Electric Company., Koninklijke Philips N.V., Abbott, Deltex Medical Limited, NIMedical, LiDCO Ltd., Conmed Corporation, and Imacor are among the leading companies operating in the non-invasive cardiac output monitoring device market.

Non-Invasive Cardiac Output Monitoring Device Market , by Region, 2019 (%) 

---

Non-Invasive Cardiac Output Monitoring Device Market Size & Growth by 2027

Download Free Sample

---

Non-Invasive Cardiac Output Monitoring Device Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Device (Patches, Wristwatches, and Probes and Catheters), Indication (Hypertension, Coronary Diseases, Congenital Problems, Myocardial Ischemia and Infarction, Heart Failure, Arrhythmias, and Others) and End User (Hospitals, Emergency Services Centers, Homecare, and Others) and Geography

The report segments global non-invasive cardiac output monitoring device market as follows:

By Device

• Patches
• Wristwatches
• Probes and Catheters

By Indication

• Hypertension
• Coronary Diseases
• Congenital Problems
• Myocardial Ischemia and Infarction
• Heart Failure
• Arrhythmias
• Others

By End User

• Hospitals
• Emergency Services Centers
• Homecare
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • UK
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific (APAC)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East and Africa (MEA)
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of Middle East and Africa
• South and Central America (SCAM)
  • Brazil
  • Argentina
  • Rest of South and Central America